In one paragraphArticle in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Flavia CaridiDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0001-6378-9983 Patricia Mingo-CasasDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0003-1207-240X Ana EstebanDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0001-7061-7207 Teresa PoderosoDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0002-1406-000X Nereida Jiménez de OyaDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0003-3129-813X Bo ZhangState Key Laboratory of Virology and Biosafety, Chinese Academy of Sciences, Wuhan Institute of Virology, Wuhan, People's Republic of China.ORCID 0000-0002-8895-3679 Ana-Belén BlázquezDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0002-0847-0977 Miguel A Martín-AcebesDepartment of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Consejo Superior de Investigaciones Científicas (INIA-CSIC), Madrid, Spain.ORCID 0000-0001-6015-3613 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
West Nile virus (WNV) is a zoonotic
Indexed as
Antiviral AgentsTriglyceridesWest Nile FeverWest Nile virusAnimalsBrainCytokinesFemaleHumansLipid DropletsLipid MetabolismMiceMice, Inbred C57BLMosquito-Borne DiseasesVirus ReplicationAntiviral AgentsCytokinesTriglyceridesantivirallipidneuroinflammationtriacylglycerolWest Nile virus
Identifiers
PMID42678221
PMCPMC13591993
What OpenQuestion holds
Textmetadata
Read underepoch 390